Format

Send to

Choose Destination
Appl Physiol Nutr Metab. 2016 Aug;41(8):850-5. doi: 10.1139/apnm-2016-0053. Epub 2016 Apr 1.

Low and moderate doses of caffeine late in exercise improve performance in trained cyclists.

Author information

1
a Exercise and Sports Science Department, 160 Pearl Street, EXSS Department, Fitchburg State University, Fitchburg, MA 01420, USA.
2
b Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.

Abstract

The aim of the present study was to assess if low and moderate doses of caffeine delivered in a carbohydrate-electrolyte solution (CES) late in exercise improved time-trial (TT) performance. Fifteen (11 male, 4 female) cyclists (age, 22.5 ± 0.9 years; body mass, 69.3 ± 2.6 kg; peak oxygen consumption, 64.6 ± 1.9 mL·min(-1)·kg(-1)) completed 4 double-blinded randomized trials. Subjects completed 120 min of cycling at ∼60% peak oxygen consumption with 5 interspersed 120-s intervals at ∼82% peak oxygen consumption, immediately followed by 40-s intervals at 50 W. Following 80 min of cycling, subjects either ingested a 6% CES (PL), a CES with 100 mg (low dose, 1.5 ± 0.1 mg·kg body mass(-1)) of caffeine (CAF1), or a CES with 200 mg (moderate dose, 2.9 ± 0.1 mg·kg body mass(-1)) of caffeine (CAF2). Following the 120-min cycling challenge, cyclists completed a 6-kJ·kg body mass(-1) TT. There was no difference between respiratory, heart rate, glucose, free fatty acid, body mass, hematocrit, or urine specific gravity measurements between treatments. The CAF2 (26:36 ± 0:22 min:s) TT was completed faster than CAF1 (27:36 ± 0:32 min:s, p < 0.05) and both CAF1 and CAF2 TTs were completed faster than PL (28:41 ± 0:38 min:s, p < 0.05). Blood lactate was similar between trials and rose to a greater extent during the TT (p < 0.05). In summary, both doses of caffeine delivered late in exercise improved TT performance over the PL trial and the moderate dose (CAF2) improved performance to a greater extent than the low dose (CAF1).

KEYWORDS:

agent ergogène; contre-la-montre; cycling; cyclisme; elite; ergogenic aid; exercice physique; exercise; metabolism; métabolisme; time trial; élite

PMID:
27426699
DOI:
10.1139/apnm-2016-0053
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center